Actionnariat et activité des initiés pour Grace Therapeutics, Inc. (GRCE): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.14 |
| Capitalisation | $35M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-09-09 | Opaleye Management Inc. | P-Purchase | 5,836 | $12K |
| 2026-09-08 | Opaleye Management Inc. | P-Purchase | 9,393 | $20K |
| 2026-09-09 | Kohli Prashant | P-Purchase | 100,000 | $214K |
| 2026-08-28 | Kumar Amresh | A-Award | 35,760 | $76K |
| 2026-08-28 | Kohli Prashant | A-Award | 267,160 | $566K |
| 2026-08-28 | Macdonald R. Loch | A-Award | 54,690 | $116K |
| 2026-08-28 | DelAversano Robert J | A-Award | 33,660 | $71K |
| 2026-08-14 | Opaleye Management Inc. | P-Purchase | 11,608 | $24K |
| 2026-01-08 | Kavuru Vimal | A-Award | 10,000 | $38K |
| 2026-01-08 | Kottayil George | A-Award | 10,000 | $38K |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | 0 | $6.4M | $16.9M | $20.1M | $64.0M | $30.3M | $27.9M | $23.0M | $22.1M | $17.0M |
| Placements à Court Terme | 0 | 0 | $8.9M | 0 | $12.3M | $13.3M | $15000 | 0 | 0 | 0 |
| Créances | $206167 | $759260 | $1.6M | $771811 | $665810 | $548000 | $802000 | $722000 | $126000 | $20000 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $10.2M | $7.4M | $28.0M | $22.6M | $78.4M | $45.5M | $29.3M | $24.0M | $22.7M | $17.4M |
| Immobilisations Corporelles | $2.9M | $2.2M | $2.1M | $2.9M | $108037 | $315000 | $567000 | $24000 | $15000 | $8000 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | $13.0M | $8.1M | $8.1M | $8.1M | $8.1M |
| Actifs Incorporels | $12.4M | $7.8M | $6.4M | $6.0M | 0 | $69.8M | $41.1M | $41.1M | $41.1M | $41.1M |
| Actifs Totaux | $25.5M | $17.8M | $36.9M | $32.3M | $78.5M | $128.6M | $79.1M | $73.3M | $72.0M | $66.7M |
| Dettes Fournisseurs | 0 | $2.6M | $3.0M | $2.4M | $144468 | $3.2M | $1.2M | $1.0M | $601000 | $702000 |
| Dette à Court Terme | 0 | 0 | $1.4M | $121567 | $108037 | $104000 | $75000 | 0 | 0 | 0 |
| Passifs Courants | $2.1M | $5.2M | $13.7M | $10.5M | $2.0M | $3.3M | $3.4M | $1.7M | $1.9M | $2.1M |
| Dette à Long Terme | $1.4M | $1.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $3.8M | $11.4M | $25.9M | $13.9M | $8.5M | $20.4M | $11.2M | $11.6M | $5.4M | $2.8M |
| Réserves | -$50.9M | -$56.0M | -$100.8M | -$178.6M | -$183.4M | -$155.8M | -$198.3M | -$211.1M | -$220.7M | -$228.5M |
| Capitaux Propres | $21.7M | $6.4M | $11.0M | $18.4M | $69.9M | $108.3M | $68.0M | $61.7M | $66.6M | $63.9M |
| Dette Totale | $1.4M | $1.2M | $1.4M | $207795 | $108037 | $295000 | $485000 | 0 | 0 | 0 |
| Dette Nette | -$8.4M | -$5.1M | -$24.4M | -$19.9M | -$76.2M | -$43.4M | -$27.4M | -$23.0M | -$22.1M | -$17.0M |
| Fonds de Roulement | $8.1M | $2.2M | $14.3M | $12.1M | $76.4M | $42.3M | $25.9M | $22.3M | $20.8M | $15.2M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 11.47 |
| Piotroski F-Score | 1 |
| Altman Z-Score | 11.56 |
Rentabilité
| Rentabilité des capitaux propres | -35.78% |
| Rentabilité du capital investi | -48.75% |
| Rentabilité des actifs | -42.84% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ABVC · ATNM · CALC · LTRN · LVTX · OKUR · PDSB
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de GRCE: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions